A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire
► We studied genetic modification of arsenic associated bladder cancer risk. ► GSTP1 Ile105Val variant was associated with an increased risk of arsenic-related bladder cancer. ► AQP3 Phe130Phe carriers had a possible increased risk of arsenic-related bladder cancer. ► GSTO2 Asn142Asp and GSTZ1 Glu32...
Gespeichert in:
| Veröffentlicht in: | Toxicology letters 2012-04, Vol.210 (1), p.100-106 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 106 |
|---|---|
| container_issue | 1 |
| container_start_page | 100 |
| container_title | Toxicology letters |
| container_volume | 210 |
| creator | Lesseur, Corina Gilbert-Diamond, Diane Andrew, Angeline S. M. Ekstrom, Rebecca Li, Zhongze Kelsey, Karl T. Marsit, Carmen J. Karagas, Margaret R. |
| description | ► We studied genetic modification of arsenic associated bladder cancer risk. ► GSTP1 Ile105Val variant was associated with an increased risk of arsenic-related bladder cancer. ► AQP3 Phe130Phe carriers had a possible increased risk of arsenic-related bladder cancer. ► GSTO2 Asn142Asp and GSTZ1 Glu32Lys were associated with overall bladder cancer risk.
Arsenic is associated with bladder cancer risk even at low exposure levels. Genetic variation in enzymes involved in xenobiotic and arsenic metabolism may modulate individual susceptibility to arsenic-related bladder cancer. Through a population-based case-control study in NH (832 cases and 1191 controls), we investigated gene-environment interactions between arsenic metabolic gene polymorphisms and arsenic exposure in relation to bladder cancer risk. Toenail arsenic concentrations were used to classify subjects into low and high exposure groups. Single nucleotide polymorphisms (SNPs) in GSTP1, GSTO2, GSTZ1, AQP3, AS3MT and the deletion status of GSTM1 and GSTT1 were determined. We found evidence of genotype-arsenic interactions in the high exposure group; GSTP1 Ile105Val homozygous individuals had an odds ratio (OR) of 5.4 [95% confidence interval (CI): 1.5–20.2; P for interaction=0.03] and AQP3 Phe130Phe carriers had an OR=2.2 (95% CI: 0.8–6.1; P for interaction=0.10). Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0–1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9–1.8; P for trend=0.06). Our findings suggest that susceptibility to bladder cancer may relate to variation in genes involved in arsenic metabolism and oxidative stress response and potential gene-environment interactions requiring confirmation in other populations. |
| doi_str_mv | 10.1016/j.toxlet.2012.01.015 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3374400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378427412000380</els_id><sourcerecordid>22306368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-19ab3ecf13a4a958756263d4438c05e119a8dd40623b3cd6a115c37937f1e1c93</originalsourceid><addsrcrecordid>eNp9UctqHDEQFCEm3tj5gxB0yXE20ug1cwkYk8QBY1-Ss9BIPV4tmtEgyY-958Mjs35eDA0tqOpqdRVCnylZU0Llt-26xLsAZd0S2q4JrSXeoRXtVN8wKvv3aEWY6hreKn6IPua8JYRILsUHdNi2jEgmuxX6d4KtydDYOJcUA87l2u1wHPESw26Kadn4PGXsZ3wHcxx8LN5iMztsUoa5vicoZoihsvAVzJBfgk2CYAo4PATjHKS6ara1VbULuMVnZlryxic4RgejCRk-PfQj9Pfnjz-nZ8355a_fpyfnjRWiKw3tzcDAjpQZbnrRKSFbyRznrLNEAK145xwnsmUDs04aSoVlqmdqpEBtz47Q973ucj1M4CzUm03QS_KTSTsdjdevkdlv9FW80YwpzgmpAnwvYFPMOcH4NEuJvk9Fb_U-FX2fiia0lqhjX17ufRp6jKESvj4QTLYmjKn65PMzTyjBO6meD4Dq0o2HpLP1UD111UVbtIv-7Z_8B0jJsMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lesseur, Corina ; Gilbert-Diamond, Diane ; Andrew, Angeline S. ; M. Ekstrom, Rebecca ; Li, Zhongze ; Kelsey, Karl T. ; Marsit, Carmen J. ; Karagas, Margaret R.</creator><creatorcontrib>Lesseur, Corina ; Gilbert-Diamond, Diane ; Andrew, Angeline S. ; M. Ekstrom, Rebecca ; Li, Zhongze ; Kelsey, Karl T. ; Marsit, Carmen J. ; Karagas, Margaret R.</creatorcontrib><description>► We studied genetic modification of arsenic associated bladder cancer risk. ► GSTP1 Ile105Val variant was associated with an increased risk of arsenic-related bladder cancer. ► AQP3 Phe130Phe carriers had a possible increased risk of arsenic-related bladder cancer. ► GSTO2 Asn142Asp and GSTZ1 Glu32Lys were associated with overall bladder cancer risk.
Arsenic is associated with bladder cancer risk even at low exposure levels. Genetic variation in enzymes involved in xenobiotic and arsenic metabolism may modulate individual susceptibility to arsenic-related bladder cancer. Through a population-based case-control study in NH (832 cases and 1191 controls), we investigated gene-environment interactions between arsenic metabolic gene polymorphisms and arsenic exposure in relation to bladder cancer risk. Toenail arsenic concentrations were used to classify subjects into low and high exposure groups. Single nucleotide polymorphisms (SNPs) in GSTP1, GSTO2, GSTZ1, AQP3, AS3MT and the deletion status of GSTM1 and GSTT1 were determined. We found evidence of genotype-arsenic interactions in the high exposure group; GSTP1 Ile105Val homozygous individuals had an odds ratio (OR) of 5.4 [95% confidence interval (CI): 1.5–20.2; P for interaction=0.03] and AQP3 Phe130Phe carriers had an OR=2.2 (95% CI: 0.8–6.1; P for interaction=0.10). Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0–1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9–1.8; P for trend=0.06). Our findings suggest that susceptibility to bladder cancer may relate to variation in genes involved in arsenic metabolism and oxidative stress response and potential gene-environment interactions requiring confirmation in other populations.</description><identifier>ISSN: 0378-4274</identifier><identifier>EISSN: 1879-3169</identifier><identifier>DOI: 10.1016/j.toxlet.2012.01.015</identifier><identifier>PMID: 22306368</identifier><identifier>CODEN: TOLED5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Arsenic ; Arsenic Poisoning - genetics ; Arsenicals - metabolism ; Biological and medical sciences ; Bladder cancer ; Carcinogenesis, carcinogens and anticarcinogens ; Case-Control Studies ; Case-control study ; Chemical agents ; Chemical and industrial products toxicology. Toxic occupational diseases ; Environmental Exposure ; Female ; Gene Deletion ; Gene-Environment Interaction ; Genetic polymorphisms ; Genotype ; Homozygote ; Humans ; Male ; Medical sciences ; Metals and various inorganic compounds ; Middle Aged ; Nephrology. Urinary tract diseases ; New Hampshire - epidemiology ; Polymorphism, Genetic - genetics ; Polymorphism, Single Nucleotide - genetics ; Toxicology ; Tumors ; Tumors of the urinary system ; Urinary Bladder Neoplasms - chemically induced ; Urinary Bladder Neoplasms - genetics ; Urinary system involvement in other diseases. Miscellaneous ; Urinary tract. Prostate gland ; Xenobiotics - metabolism ; Xenobiotics - toxicity</subject><ispartof>Toxicology letters, 2012-04, Vol.210 (1), p.100-106</ispartof><rights>2012 Elsevier Ireland Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.</rights><rights>2012 Elsevier Ireland Ltd. All rights reserved. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-19ab3ecf13a4a958756263d4438c05e119a8dd40623b3cd6a115c37937f1e1c93</citedby><cites>FETCH-LOGICAL-c558t-19ab3ecf13a4a958756263d4438c05e119a8dd40623b3cd6a115c37937f1e1c93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.toxlet.2012.01.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25754867$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22306368$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lesseur, Corina</creatorcontrib><creatorcontrib>Gilbert-Diamond, Diane</creatorcontrib><creatorcontrib>Andrew, Angeline S.</creatorcontrib><creatorcontrib>M. Ekstrom, Rebecca</creatorcontrib><creatorcontrib>Li, Zhongze</creatorcontrib><creatorcontrib>Kelsey, Karl T.</creatorcontrib><creatorcontrib>Marsit, Carmen J.</creatorcontrib><creatorcontrib>Karagas, Margaret R.</creatorcontrib><title>A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire</title><title>Toxicology letters</title><addtitle>Toxicol Lett</addtitle><description>► We studied genetic modification of arsenic associated bladder cancer risk. ► GSTP1 Ile105Val variant was associated with an increased risk of arsenic-related bladder cancer. ► AQP3 Phe130Phe carriers had a possible increased risk of arsenic-related bladder cancer. ► GSTO2 Asn142Asp and GSTZ1 Glu32Lys were associated with overall bladder cancer risk.
Arsenic is associated with bladder cancer risk even at low exposure levels. Genetic variation in enzymes involved in xenobiotic and arsenic metabolism may modulate individual susceptibility to arsenic-related bladder cancer. Through a population-based case-control study in NH (832 cases and 1191 controls), we investigated gene-environment interactions between arsenic metabolic gene polymorphisms and arsenic exposure in relation to bladder cancer risk. Toenail arsenic concentrations were used to classify subjects into low and high exposure groups. Single nucleotide polymorphisms (SNPs) in GSTP1, GSTO2, GSTZ1, AQP3, AS3MT and the deletion status of GSTM1 and GSTT1 were determined. We found evidence of genotype-arsenic interactions in the high exposure group; GSTP1 Ile105Val homozygous individuals had an odds ratio (OR) of 5.4 [95% confidence interval (CI): 1.5–20.2; P for interaction=0.03] and AQP3 Phe130Phe carriers had an OR=2.2 (95% CI: 0.8–6.1; P for interaction=0.10). Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0–1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9–1.8; P for trend=0.06). Our findings suggest that susceptibility to bladder cancer may relate to variation in genes involved in arsenic metabolism and oxidative stress response and potential gene-environment interactions requiring confirmation in other populations.</description><subject>Adult</subject><subject>Aged</subject><subject>Arsenic</subject><subject>Arsenic Poisoning - genetics</subject><subject>Arsenicals - metabolism</subject><subject>Biological and medical sciences</subject><subject>Bladder cancer</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Case-Control Studies</subject><subject>Case-control study</subject><subject>Chemical agents</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Environmental Exposure</subject><subject>Female</subject><subject>Gene Deletion</subject><subject>Gene-Environment Interaction</subject><subject>Genetic polymorphisms</subject><subject>Genotype</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metals and various inorganic compounds</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>New Hampshire - epidemiology</subject><subject>Polymorphism, Genetic - genetics</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Toxicology</subject><subject>Tumors</subject><subject>Tumors of the urinary system</subject><subject>Urinary Bladder Neoplasms - chemically induced</subject><subject>Urinary Bladder Neoplasms - genetics</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><subject>Urinary tract. Prostate gland</subject><subject>Xenobiotics - metabolism</subject><subject>Xenobiotics - toxicity</subject><issn>0378-4274</issn><issn>1879-3169</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctqHDEQFCEm3tj5gxB0yXE20ug1cwkYk8QBY1-Ss9BIPV4tmtEgyY-958Mjs35eDA0tqOpqdRVCnylZU0Llt-26xLsAZd0S2q4JrSXeoRXtVN8wKvv3aEWY6hreKn6IPua8JYRILsUHdNi2jEgmuxX6d4KtydDYOJcUA87l2u1wHPESw26Kadn4PGXsZ3wHcxx8LN5iMztsUoa5vicoZoihsvAVzJBfgk2CYAo4PATjHKS6ara1VbULuMVnZlryxic4RgejCRk-PfQj9Pfnjz-nZ8355a_fpyfnjRWiKw3tzcDAjpQZbnrRKSFbyRznrLNEAK145xwnsmUDs04aSoVlqmdqpEBtz47Q973ucj1M4CzUm03QS_KTSTsdjdevkdlv9FW80YwpzgmpAnwvYFPMOcH4NEuJvk9Fb_U-FX2fiia0lqhjX17ufRp6jKESvj4QTLYmjKn65PMzTyjBO6meD4Dq0o2HpLP1UD111UVbtIv-7Z_8B0jJsMA</recordid><startdate>20120405</startdate><enddate>20120405</enddate><creator>Lesseur, Corina</creator><creator>Gilbert-Diamond, Diane</creator><creator>Andrew, Angeline S.</creator><creator>M. Ekstrom, Rebecca</creator><creator>Li, Zhongze</creator><creator>Kelsey, Karl T.</creator><creator>Marsit, Carmen J.</creator><creator>Karagas, Margaret R.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120405</creationdate><title>A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire</title><author>Lesseur, Corina ; Gilbert-Diamond, Diane ; Andrew, Angeline S. ; M. Ekstrom, Rebecca ; Li, Zhongze ; Kelsey, Karl T. ; Marsit, Carmen J. ; Karagas, Margaret R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-19ab3ecf13a4a958756263d4438c05e119a8dd40623b3cd6a115c37937f1e1c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Arsenic</topic><topic>Arsenic Poisoning - genetics</topic><topic>Arsenicals - metabolism</topic><topic>Biological and medical sciences</topic><topic>Bladder cancer</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Case-Control Studies</topic><topic>Case-control study</topic><topic>Chemical agents</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Environmental Exposure</topic><topic>Female</topic><topic>Gene Deletion</topic><topic>Gene-Environment Interaction</topic><topic>Genetic polymorphisms</topic><topic>Genotype</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metals and various inorganic compounds</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>New Hampshire - epidemiology</topic><topic>Polymorphism, Genetic - genetics</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Toxicology</topic><topic>Tumors</topic><topic>Tumors of the urinary system</topic><topic>Urinary Bladder Neoplasms - chemically induced</topic><topic>Urinary Bladder Neoplasms - genetics</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><topic>Urinary tract. Prostate gland</topic><topic>Xenobiotics - metabolism</topic><topic>Xenobiotics - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lesseur, Corina</creatorcontrib><creatorcontrib>Gilbert-Diamond, Diane</creatorcontrib><creatorcontrib>Andrew, Angeline S.</creatorcontrib><creatorcontrib>M. Ekstrom, Rebecca</creatorcontrib><creatorcontrib>Li, Zhongze</creatorcontrib><creatorcontrib>Kelsey, Karl T.</creatorcontrib><creatorcontrib>Marsit, Carmen J.</creatorcontrib><creatorcontrib>Karagas, Margaret R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Toxicology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lesseur, Corina</au><au>Gilbert-Diamond, Diane</au><au>Andrew, Angeline S.</au><au>M. Ekstrom, Rebecca</au><au>Li, Zhongze</au><au>Kelsey, Karl T.</au><au>Marsit, Carmen J.</au><au>Karagas, Margaret R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire</atitle><jtitle>Toxicology letters</jtitle><addtitle>Toxicol Lett</addtitle><date>2012-04-05</date><risdate>2012</risdate><volume>210</volume><issue>1</issue><spage>100</spage><epage>106</epage><pages>100-106</pages><issn>0378-4274</issn><eissn>1879-3169</eissn><coden>TOLED5</coden><abstract>► We studied genetic modification of arsenic associated bladder cancer risk. ► GSTP1 Ile105Val variant was associated with an increased risk of arsenic-related bladder cancer. ► AQP3 Phe130Phe carriers had a possible increased risk of arsenic-related bladder cancer. ► GSTO2 Asn142Asp and GSTZ1 Glu32Lys were associated with overall bladder cancer risk.
Arsenic is associated with bladder cancer risk even at low exposure levels. Genetic variation in enzymes involved in xenobiotic and arsenic metabolism may modulate individual susceptibility to arsenic-related bladder cancer. Through a population-based case-control study in NH (832 cases and 1191 controls), we investigated gene-environment interactions between arsenic metabolic gene polymorphisms and arsenic exposure in relation to bladder cancer risk. Toenail arsenic concentrations were used to classify subjects into low and high exposure groups. Single nucleotide polymorphisms (SNPs) in GSTP1, GSTO2, GSTZ1, AQP3, AS3MT and the deletion status of GSTM1 and GSTT1 were determined. We found evidence of genotype-arsenic interactions in the high exposure group; GSTP1 Ile105Val homozygous individuals had an odds ratio (OR) of 5.4 [95% confidence interval (CI): 1.5–20.2; P for interaction=0.03] and AQP3 Phe130Phe carriers had an OR=2.2 (95% CI: 0.8–6.1; P for interaction=0.10). Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0–1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9–1.8; P for trend=0.06). Our findings suggest that susceptibility to bladder cancer may relate to variation in genes involved in arsenic metabolism and oxidative stress response and potential gene-environment interactions requiring confirmation in other populations.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>22306368</pmid><doi>10.1016/j.toxlet.2012.01.015</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0378-4274 |
| ispartof | Toxicology letters, 2012-04, Vol.210 (1), p.100-106 |
| issn | 0378-4274 1879-3169 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3374400 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Aged Arsenic Arsenic Poisoning - genetics Arsenicals - metabolism Biological and medical sciences Bladder cancer Carcinogenesis, carcinogens and anticarcinogens Case-Control Studies Case-control study Chemical agents Chemical and industrial products toxicology. Toxic occupational diseases Environmental Exposure Female Gene Deletion Gene-Environment Interaction Genetic polymorphisms Genotype Homozygote Humans Male Medical sciences Metals and various inorganic compounds Middle Aged Nephrology. Urinary tract diseases New Hampshire - epidemiology Polymorphism, Genetic - genetics Polymorphism, Single Nucleotide - genetics Toxicology Tumors Tumors of the urinary system Urinary Bladder Neoplasms - chemically induced Urinary Bladder Neoplasms - genetics Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Xenobiotics - metabolism Xenobiotics - toxicity |
| title | A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A58%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case-control%20study%20of%20polymorphisms%20in%20xenobiotic%20and%20arsenic%20metabolism%20genes%20and%20arsenic-related%20bladder%20cancer%20in%20New%20Hampshire&rft.jtitle=Toxicology%20letters&rft.au=Lesseur,%20Corina&rft.date=2012-04-05&rft.volume=210&rft.issue=1&rft.spage=100&rft.epage=106&rft.pages=100-106&rft.issn=0378-4274&rft.eissn=1879-3169&rft.coden=TOLED5&rft_id=info:doi/10.1016/j.toxlet.2012.01.015&rft_dat=%3Cpubmed_cross%3E22306368%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22306368&rft_els_id=S0378427412000380&rfr_iscdi=true |